AI Commercial Team (AIC):
The AI Commercial team, is part of the newly founded Enterprise AI team (EAI), delivering AI strategy and coordinated commercial progress and programs, in close collaboration with our business teams, and in partnership with our enterprise teams. We lead cross-functional and commercial-wide initiatives to deliver transformative commercial value and ensure we are at our best in delivering lifesaving medicines to patients.
AI Commercial Business Leaders are the embedded “translators” between business functions and the AI Commercial organization, responsible for the success of AI programs. The role is strategically positioned in therapy areas, markets, and functions with the objectives to drive translation, adoption, and lifecycle management of AI solutions in the business.
Key deliverables include translating business needs into well-scoped AI use cases and ensure each solution delivers measurable business impact. This requires you to be bilingual in business/science and technology, enabling you to connect domain priorities with AI delivery teams. You will be responsible for owning the full lifecycle of AI solutions - from ideation through delivery, adoption, and decommissioning - and are accountable for driving real, sustained value and reuse.
In this role, you will be responsible for building the bridge between business teams at a Region and Market level, and technical experts within the AIC and EAI function as well as key other Enterprise technology teams such as Commercial IT and Global Business Services. As part of this role, you will champion the key commercial AI programs in service of enhancing customer engagement, powered by actionable AI insights, delivered thought agentic platforms. In addition, you will partner on the delivery of AI capability building programs.
To do this successfully, you will share geographic location with the respective Region team, have a seat at the Senior leader table for the Region, with connection further enhanced through dotted line reporting to the Region, while sitting on the AIC Leadership team reporting to VP AIC.
Oncology Business Unit (OBU) is responsible for the commercialisation of medicines across some of the most hard-to-treat forms of disease, including: lung, breast, gastrointestinal, gynaecological, genitourinary and haematology cancers.